Inna Zilberleyb
Genesys (United States)(US)PDL BioPharma (United States)(US)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Neuroscience and Neuropharmacology Research, Bacterial Genetics and Biotechnology, Ion channel regulation and function, Cellular transport and secretion
Most-Cited Works
- → Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability(2013)406 cited
- → Structural basis for dual-mode inhibition of the ABC transporter MsbA(2018)174 cited
- → Wnt Antagonists Bind through a Short Peptide to the First β-Propeller Domain of LRP5/6(2011)167 cited
- → Targeted degradation via direct 26S proteasome recruitment(2022)104 cited
- → HectD1 E3 Ligase Modifies Adenomatous Polyposis Coli (APC) with Polyubiquitin to Promote the APC-Axin Interaction(2013)68 cited
- → Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation(2014)61 cited
- → Structural insights into lipoprotein N-acylation by Escherichia coli apolipoprotein N-acyltransferase(2017)57 cited
- → Modulation of K11-Linkage Formation by Variable Loop Residues within UbcH5A(2011)45 cited
- → A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies(2018)37 cited
- → Nanolipoprotein Particles as a Delivery Platform for Fab Based Therapeutics(2020)13 cited